Day Eightyone

Some good news hot from twitter right now. 
Moderna's Press Release to the investors says Phase 3 trials will begin next month with 30,000 participants. In parallel the company is also going ahead with plans to manufacture 0.5-1 billion doses of 100 μg per year. Lonza is the partner for manufacturing. 
The very first volunteer for the Phase I trial had an adverse reaction but still has faith in the vaccine. 

Chronicle of a Pandemic Foretold

Comments

Popular posts from this blog

Thoughts on the Pandemic

World's First Vaccine?

Day Thirtyeight